Table 1 Baseline characteristics of patients
| Characteristic |
Levofloxacin, n = 145 |
Clarithromycin, n = 100 | P value |
|---|---|---|---|
| Age | 44.8 ± 12.9 | 45.7 ± 13.9 | 0.6 |
| Sex (female) | 89 (61.4) | 60 (60) | 0.8 |
| Diagnostic test | |||
|
• CLO test • Histopathology • Stool antigen |
51 (35.2) 71 (49) 23 (15.9) |
42 (42) 48 (48) 10 (10) | 0.3 |
| Follow up test | |||
|
• CLO test • Histopathology • Stool antigen |
10 (6.9) 14 (9.7) 121 (83.4) |
7 (7) 16 (16) 77 (77) | 0.3 |
| Diabetes | 28 (19.3) | 24 (24) | 0.4 |
| EGD findings | |||
|
• Esophagus • Stomach • Duodenum • Multisite • None |
2 (1.4) 65 (44.8) 7 (4.8) 22 (15.2) 49 (33.8) |
1 (1) 54 (54) 3 (3) 20 (20) 22 (22) | 0.3 |
| Duration of the therapy | |||
|
• 10 days • 14 days |
51 (35.2) 94 (64.8) |
17 (18) 83 (83) | 0.002 |